In Petyaev et al. (2018), the authors wish to disclose the following information which should have appeared in the Conflict of Interest section:
Lycotec Ltd developed GA lycopene, which is evaluated in this study. Ivan M. Petyaev and Nigel H. Kyle are employees of Lycotec, Ltd; Dmitry V. Pristensky, Marina P. Chernyshova, Marina V. Lozbiakova, and Yuriy K. Bashmakov are independent scientists who collaborate with, but are not, full time employees of Lycotec Ltd; Pavel Dovgalevsky, Victor Klochkov, and Natalya Chalyk are employees of the Institute of Cardiology in Saratov, Russian Federation; Ruzan Udumyan and Taron Kocharyan are employees of Orebro University, Sweden. There have never been any financial relationships between Lycotec and these latter organizations.
We apologize for this error.
Reference
- Petyaev, I. M. , Dovgalevsky, P. Y. , Klochkov, V. A. , Chalyk, N. E. , Pristensky, D. V. , Chernyshova, M. P. , … Bashmakov, Y. K. (2018). Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease. Food Sciences and Nutrition, 6(6), 1770–1777. 10.1002/fsn3.734 [DOI] [PMC free article] [PubMed] [Google Scholar]